Search research articles
Contact Us
Filters
Showing results (1-10 of 109) with videos related to
Page
of 11
Sort By:
Seminars in Respiratory and Critical Care Medicine
|
November 22, 2013
Immunotherapy in lung cancer: "b7-bombers" and other new developments
Ben C Creelan, Scott J Antonia
Expert Review of Anticancer Therapy
|
December 23, 2003
Cell-based immune therapy for metastatic renal cancer
Mayer N Fishman, Scott J Antonia
Tuberculosis and Respiratory Diseases
|
January 15, 2018
Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Chi Young Jung, Scott J Antonia
Methods in Molecular Medicine
|
November 1, 2002
Gene therapy for lung cancer. An introduction
Eric B Haura, Eduardo Sotomayor, Scott J Antonia
Expert Opinion on Biological Therapy
|
January 10, 2017
PD-1 checkpoint blockade alone or combined PD-1 and CTLA-4 blockade as immunotherapy for lung cancer?
Tawee Tanvetyanon, Jhanelle E Gray, Scott J Antonia
Oncoimmunology
|
January 10, 2014
A new role for NFκB in immunosurveillance and its implications for cancer immunotherapy
Amer A Beg, Tahira Khan, Scott J Antonia
Expert Review of Anticancer Therapy
|
August 5, 2016
The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer
Tawee Tanvetyanon, Benjamin C Creelan, Scott J Antonia
Breast Cancer (Dove Medical Press)
|
January 1, 2016
A GM-CSF and CD40L bystander vaccine is effective in a murine breast cancer model
Hatem Soliman, Melanie Mediavilla-Varela, Scott J Antonia
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 2, 2016
Immunotherapy: Beyond Anti-PD-1 and Anti-PD-L1 Therapies
Scott J Antonia, Johan F Vansteenkiste, Edmund Moon
Molecular Biotechnology
|
October 4, 2003
Gene therapy for lung cancer
Eric B Haura, Eduardo Sotomayor, Scott J Antonia
Page
of 11
Search research articles
Search
Showing results (1-10 of 109) with videos related to
Sort By:
Page
of 11
Seminars in Respiratory and Critical Care Medicine
|
November 22, 2013
Immunotherapy in lung cancer: "b7-bombers" and other new developments
Ben C Creelan, Scott J Antonia
Expert Review of Anticancer Therapy
|
December 23, 2003
Cell-based immune therapy for metastatic renal cancer
Mayer N Fishman, Scott J Antonia
Tuberculosis and Respiratory Diseases
|
January 15, 2018
Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Chi Young Jung, Scott J Antonia
Methods in Molecular Medicine
|
November 1, 2002
Gene therapy for lung cancer. An introduction
Eric B Haura, Eduardo Sotomayor, Scott J Antonia
Expert Opinion on Biological Therapy
|
January 10, 2017
PD-1 checkpoint blockade alone or combined PD-1 and CTLA-4 blockade as immunotherapy for lung cancer?
Tawee Tanvetyanon, Jhanelle E Gray, Scott J Antonia
Oncoimmunology
|
January 10, 2014
A new role for NFκB in immunosurveillance and its implications for cancer immunotherapy
Amer A Beg, Tahira Khan, Scott J Antonia
Expert Review of Anticancer Therapy
|
August 5, 2016
The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer
Tawee Tanvetyanon, Benjamin C Creelan, Scott J Antonia
Breast Cancer (Dove Medical Press)
|
January 1, 2016
A GM-CSF and CD40L bystander vaccine is effective in a murine breast cancer model
Hatem Soliman, Melanie Mediavilla-Varela, Scott J Antonia
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 2, 2016
Immunotherapy: Beyond Anti-PD-1 and Anti-PD-L1 Therapies
Scott J Antonia, Johan F Vansteenkiste, Edmund Moon
Molecular Biotechnology
|
October 4, 2003
Gene therapy for lung cancer
Eric B Haura, Eduardo Sotomayor, Scott J Antonia
Page
of 11